LHX insider sales: 83,000-share Rule 144 notice follows recent disposals

Rhea-AI Filing Summary

L3Harris Technologies, Inc. (LHX) Rule 144 notice shows a proposed sale of 83,000 common shares through Fidelity Brokerage Services with an aggregate market value of $23,231,539.66, scheduled approximately for 09/12/2025 on the NYSE. The filing states these shares were acquired as an option granted on 02/20/2018 and the intended payment method is cash. The filer also disclosed three prior sales by Christopher E. Kubasik within the past three months: 33,061 shares on 06/12/2025 for $8,214,825.36, 72,000 shares on 07/29/2025 for $19,521,698.40, and 40,138 shares on 08/11/2025 for $10,818,005.80. The notice includes the standard insider representation that no undisclosed material adverse information is known.

Positive

• Filer complied with Rule 144 disclosure requirements by providing acquisition details, broker information, and prior sales.
• Acquisition origin is disclosed (option granted 02/20/2018), allowing traceability of holding period compliance.

Negative

• Planned sale of 83,000 shares with an aggregate market value of $23,231,539.66 on or about 09/12/2025.
• Recent insider sales total 145,199 shares in the past three months with gross proceeds of approximately $38,554,529.56.
• No 10b5-1 plan adoption date disclosed in the form, so the filing does not indicate whether sales follow a pre-established trading plan.

Insights

Corporate Governance Expert

TL;DR: Insider disclosed planned sale under Rule 144 and recent sales, consistent with standard compliance disclosures.

The filing documents a planned Rule 144 sale of 83,000 shares valued at $23.23 million and records multiple recent insider disposals by Christopher E. Kubasik totaling 145,199 shares in the prior three months for approximately $38.55 million. From a governance perspective, the form meets disclosure requirements by identifying acquisition details (option grant date 02/20/2018), broker routing, and the seller’s attestation. The filing does not state any trading plan adoption date or provide additional context for purpose of sales, leaving only the required factual record for investors and regulators.

Securities Analyst

TL;DR: Significant insider selling activity is disclosed; this is potentially negative information for investors focused on insider alignment.

The notice shows continued insider liquidation activity: three recent sales of 33,061; 72,000; and 40,138 shares, followed by a proposed sale of 83,000 shares. Aggregate proceeds reported for those three transactions equal about $38.55 million, and the proposed sale is reported at $23.23 million market value. While the filing is compliance-driven and does not indicate issuer performance, the scale and frequency of disposals are material facts investors may view as relevant to insider sentiment and share supply.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	83000	23231539.66	187094798	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/12/2025	Option Granted 02/20/2018	Issuer			83000	09/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher E. Kubasik 1025 West NASA Boulevard Melbourne NY 32919	Common	06/12/2025	33061	8214825.36
Christopher E. Kubasik 1025 West NASA Boulevard Melbourne NY 32919	Common	07/29/2025	72000	19521698.40
Christopher E. Kubasik 1025 West NASA Boulevard Melbourne, NY 32919	Common	08/11/2025	40138	10818005.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the LHX Rule 144 filing disclose about proposed sales?

The filing discloses a proposed sale of 83,000 common shares through Fidelity with an aggregate market value of $23,231,539.66, approximately on 09/12/2025 on the NYSE.

Who reported the prior insider sales in the past three months for LHX?

Christopher E. Kubasik reported three sales: 33,061 shares on 06/12/2025 for $8,214,825.36; 72,000 on 07/29/2025 for $19,521,698.40; and 40,138 on 08/11/2025 for $10,818,005.80.

How were the proposed shares acquired according to the filing?

The 83,000 shares to be sold were acquired via an option granted on 02/20/2018, with the filing listing the issuer as the source.

Through which broker will the 83,000 LHX shares be sold?

The filing lists Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917 as the broker for the proposed sale.

Does the filing state whether the seller knows of undisclosed material information?

Yes, the signer represents they do not know any material adverse information